Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.630
-0.030 (-1.81%)
Mar 18, 2026, 2:57 PM EDT - Market open
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $51.43 million as of March 18, 2026. Its market cap has decreased by -67.86% in one year.
Market Cap
51.43M
Enterprise Value
-74.83M
1-Year Change
-67.86%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $51.43M, a decrease of -78.12%. That is a compound annual growth rate of -36.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 52.38M | -31.12% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuCell | 57.76M |
| Radiopharm Theranostics | 57.65M |
| MAIA Biotechnology | 57.03M |
| Instil Bio | 56.63M |
| Metagenomi Therapeutics | 55.68M |
| Lipocine | 53.80M |
| OnKure Therapeutics | 53.47M |
| OS Therapies | 52.82M |